Literature DB >> 19577974

[Ophthalmic manifestations in Wegener's granulomatosis. Review of literature about an observation].

Richard Montagnac1, Joseph Nyandwi, Gérard Loiselet, Jean Pradel, Francis Schillinger.   

Abstract

Wegener's granulomatosis mainly affects the upper respiratory tract, the lungs and the kidneys but many other organs and tissues may be affected, as well including any eye structures. Ocular and orbital structures involvement is frequently encountered, sometimes inaugural, with or without obvious systemic manifestations, sometimes leading to visual loss. The most frequent ophthalmic lesions are inflammatory orbital disease, (necrotising) scleritis with or without keratopathy, episcleritis, conjunctivitis and even conjunctival ulcer, nasolacrimal ducts obstruction, uveitis, retinal vasculitis and even central retinal vascular occlusion, optic neuritis. These ocular lesions result either from extensive granulomatous inflammation or from focal vasculitis. These complications need to be recognized as soon as possible so that an early diagnosis may allow the appropriate treatment meant to keep both visual and even general prognosis.

Entities:  

Mesh:

Year:  2009        PMID: 19577974     DOI: 10.1016/j.nephro.2009.05.003

Source DB:  PubMed          Journal:  Nephrol Ther        ISSN: 1769-7255            Impact factor:   0.722


  3 in total

1.  Clinical approach to optic neuritis: pitfalls, red flags and differential diagnosis.

Authors:  Elke Voss; Peter Raab; Corinna Trebst; Martin Stangel
Journal:  Ther Adv Neurol Disord       Date:  2011-03       Impact factor: 6.570

2.  Bilateral orbital mass lesions: a presentation of Wegener's granulomatosis.

Authors:  Maryam Aletaha; Mehdi Tavakoli; Mozhgan Rezaei Kanavi; Ali Hashemlou; Shiva Roghaei
Journal:  J Ophthalmic Vis Res       Date:  2011-07

3.  Granulomatosis with Polyangiitis with Ocular Manifestations.

Authors:  Lukpan Orazbekov; Botagoz Issergepova; Makpal Assainova; Kairat Ruslanuly
Journal:  Case Rep Ophthalmol       Date:  2021-04-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.